Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complicated Skin and Soft Tissue,cSSTI”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableStudy completedNCT01293435
What this trial is testing

Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin Infections

Who this might be right for
Community Acquired Pneumonia (CAP)Complicated Skin and Skin Structures Infections (cSSSI)
AstraZeneca 4,035
Not applicableActive Not RecruitingNCT06959667
What this trial is testing

Comparative Analysis of Nemonoxacin and Other Anti-methicillin Resistant Staphylococcus Aureus (Anti-MRSA) Antimicrobial Therapy in Patients With Complicated Skin and Soft Tissue Infections (cSSTI): a Retrospective Chart Review Study

Who this might be right for
Methicillin-susceptible S. Aureus (MSSA)Anti-methicillin Resistant Staphylococcus Aureus (Anti-MRSA)Complicated Skin and Soft Tissue,cSSTI
National Taiwan University Hospital 144
Not applicableStudy completedNCT00827541
What this trial is testing

Post-Authorization Study Evaluating Safety Of Tigecycline

Who this might be right for
Intra-Abdominal InfectionsSkin Disease, InfectiousSoft Tissues Infections
Pfizer 115
Testing effectiveness (Phase 2)Study completedNCT03643952
What this trial is testing

Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)

Who this might be right for
BacteremiaSoft Tissue InfectionsSkin Diseases, Infectious
Merck Sharp & Dohme LLC 18
Large-scale testing (Phase 3)Ended earlyNCT00430937
What this trial is testing

Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections

Who this might be right for
Skin Diseases, InfectiousSoft Tissue Infections
Novartis Pharmaceuticals 194
Large-scale testing (Phase 3)Study completedNCT02276482
What this trial is testing

Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)

Who this might be right for
Skin Diseases, InfectiousSkin Diseases, Bacterial
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 120
Large-scale testing (Phase 3)Ended earlyNCT02202135
What this trial is testing

Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.

Who this might be right for
Complicated Skin and Soft Tissue Infection
Pfizer 4
Not applicableStudy completedNCT00737269
What this trial is testing

A Complicated Skin and Soft-tissue Infection Patient Registry

Who this might be right for
Staphylococcal Skin InfectionsDiabetic Foot InfectionsSurgical Wound Infection+2 more
Ortho-McNeil Janssen Scientific Affairs, LLC 1,081
Large-scale testing (Phase 3)Study completedNCT01499277
What this trial is testing

Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections

Who this might be right for
Complicated Skin and Soft Tissue Infection
Pfizer 802
Large-scale testing (Phase 3)Study completedNCT01184872
What this trial is testing

Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections

Who this might be right for
Infections
Novartis Pharmaceuticals 120
Not applicableStudy completedNCT04198571
What this trial is testing

Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries

Who this might be right for
Community Acquired PneumoniaComplicated Skin and Soft Tissue Infection
Pfizer 317